Depression and anxiety as comorbid disorders in patients with Type II diabetes

2016-11-22T07-55-59Z
Source: International Journal of Medical Science and Public Health
Gautami Nagabhirava, Maithili Umate, Swateja Nimkar, Akhil Goel, Avinash Desousa.
Background: India is on the verge of a potential epidemic for Type II diabetes with the second highest diabetic population in the world. Similarly, depression and anxiety are global mental health disorders of public health importance. Objective: The purpose of this study was to assess the relationship between comorbid anxiety and depression with patients of Type II diabetes mellitus in an urban metropolis. Materials and Methods: This research uses a cross-sectional study design with a sample of 100 consecutive male and female adult patients drawn from the study population of Type II diabetes mellitus patients. They were asked to complete the problem areas in diabetes scale (PAID), Patient health questionnaire-9, general anxiety disorder-7, and were clinically screened for depression. Patients socioeconomic status and diabetes-related healthcare utilization were also assessed. Results: The prevalence of depression and anxiety was 62% and 49%, respectively, while 39% of the subjects had comorbid anxiety and depression. There was a significant positive correlation between PAID scores and comorbid anxiety/depression (ρ = 0.663, P

http://ift.tt/2gdWXV6